* Harrow Health Inc HROW.OQ reported a quarterly adjusted
loss
of 22 cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 5 cents per share.
* Revenue rose 18% to $26.10 million from a year ago;
analysts
expected $25.15 million.
* Harrow Health Inc's reported EPS for the quarter was a
loss
of 22 cents.
* The mean earnings estimate of analysts had fallen by
about 5,433% in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Harrow Health Inc shares had risen by 31.0% this
quarter and
gained 87.9% so far this year.
* The company reported a quarterly loss of $6.64 million.
* Wall Street's median 12-month price target for Harrow
Health Inc
is $37.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
11 at 09:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.05 -0.22 Missed
Dec. 31 2022 -0.12 0.04 Beat
Sep. 30 2022 0.00 -0.24 Missed
Jun. 30 2022 -0.01 -0.23 Missed